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Research, Education, and Economics 
National Agricultural Research, Extension, Education, and Economics Advisory 
Board Science Advisory Council 
 
 
USE OF GENE EDITING IN USDA RESEARCH 
Date: September 30, 2017 
 
Background 
The Science Advisory Council was established in FY2016 as a subcommittee of the National Agricultural 
Research, Extension, Education, and Economics (NAREEE) Advisory Board by the Chief Scientist as a 
result of recommendations from the 2012 report on Agricultural Preparedness by the President’s Council 
of Advisors on Science and Technology. The Council's charge is to provide advice and guidance, on a 
scientific basis, on the overall strength, practicality, and direction of agricultural research, including 
emerging technology and scientific issues and report any findings publicly to the NAREEE Advisory 
Board. 
The USDA Chief Scientist first asked the Council to examine rigor and reproducibility in USDA science. 
The second was to review the technology of Gene Editing in view of its possible use by USDA to address 
challenges. 
The term gene editing or genome editing is a generally considered a type of genetic engineering in which 
DNA is inserted, deleted or replaced in the genome of a living organism using engineered nucleases, 
sometimes referred to using a common description of molecular scissors. The nucleases used in this 
function create breaks in the target locations in the genome. These breaks are repaired leading to specific 
edits. There are currently a series of engineered nucleases being used to affect these edits. One of the most 
commonly known is the CRISPR-Cas system. 
In traditional breeding, a desired phenotype is observed and then if the approach is available, the expense 
warrants it and the tools are available; the genetic basis for the phenotype is studied and elucidated. In the 
use of a gene editing approach, a reverse of traditional breeding is done in that a sequence of DNA is 
modified and a phenotypic response is monitored. In this sense of study, gene editing holds great promise 
to understand better the role of single genes and their possible effect on a product and to modify them 
for improved human value. 
Gene editing is a tool to be used by molecular researchers, hopefully in consultations with breeders, to 
enhance the search for improved products and solutions. It joins many other tools used by USDA 
scientists such as selective breeding, cross breeding, marker assisted selection / genomic selection, etc. to 




The Science Advisory Council (the council) was asked to reflect on the issue of gene editing in USDA 
research. The council met by phone and face to face in discussion regarding gene editing technology. The 
council drafted a version of this report and then met by conference call to discuss the details of the report. 
The council primarily addressed the following question: What actions should USDA take, if any, to 
understand better, leverage, and/ or communicate gene editing technology? To help the council address 
this we broke the issue into six component parts that are presented as questions to be addressed: 
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1) Does USDA need to establish or adopt an existing definition of gene editing, and if so, for 
what purpose; if establishing a new definition, does this need to relate to other existing 
definitions? 
From a scientific standpoint, the important aspect of gene editing enabled by CRISPR/Cas technology 
is its facilitation of the process of changes in construction. The end result of insertion/deletion of 
these changes in plant and animal genes is not essentially different than previous technologies. The 
proposed new APHIS rule focuses on the end result of gene editing, and according to the proposed 
APHIS definition of “genetic engineering”, gene editing by CRISPR/Cas would not be regulated. 
The Science Advisory Council considers this to be appropriate because the end result, 
insertion/deletions in animal and plant genes, would be appropriate for APHIS review and approval. 
Oversight by APHIS of animals and plants with altered genomes by CRISPR/Cas technology would 
help ensure domestic public confidence in these genetically engineered organisms, and it would 
enhance USDA’s global leadership role in regulating genetically engineered organisms, which could 
facilitate international acceptance of these organisms. 
  
The Science Advisory Council supports the use of CRISPR/Cas technology to facilitate improvement 
of animal and plant genomes, to improve U.S. agriculture in general and to address problems that limit 
U.S. agriculture. APHIS should be prepared for potentially increased number of reviews of 
genetically engineered organisms as the technology is applied more frequently and the technology 
continues to improve. More proactive education of public on the benefits of gene editing as well as 
APHIS oversight is recommended to prevent public concern. 
 
 
2) USDA has not in the past focused on the use of specific techniques for plant and animal 
improvement but has rather focused on developing solutions to particular agricultural 
problems. Is there an overriding reason for changing that approach in the case of gene 
editing? 
After discussion, the council unanimously agreed that gene editing should be treated as other 
techniques and is, in essence, another ‘tool in the tool box’. Thus, the current USDA approach should 
continue with its focus on developing solutions to particular agricultural problems. One advantage of 
this approach is that the most applicable, cost-effective and least risky approach can be applied to 
specific problems. Further, regulation of new varietals considers their attributes, a product-based 
regulatory framework not a process-based one (reference: Precision Genome Engineering and 
Agriculture: Opportunities and Regulatory Challenges at http://journals.plos.org/plosbiology/article? 
id=10.1371/journal.pbio.1001877 and Precision Genome Engineering and Agriculture: Opportunities 
and Regulatory Challenges at https://singularityhub.com/2017/03/28/how-to-feed-9-7-billion-people- 
crispr-gene-editing-for-crops/ ) Further, the council strongly concurred that the present approach 
focuses on the solutions needed to critical challenges in agricultural, which is the most appropriate 
strategic prioritization of limited resources for success. 
 
The council also clearly perceived the need to educate the public first and apply the technology 
based on the emerging evidence second. As discussed below, benefits of this technology will only 
be realized if there is a social license that recognizes the balance of the costs for using gene editing 
versus the costs of not using it. To this end, the case study surrounding the risk of the Zika virus and 
the widespread application of the applicable pesticide and its inherent risks to the population far 
outweighed the negligible risk of using gene-edited biologic controls to limit the spread of the 
virus. This example may be useful in communicating through a specific example the importance 
and strategic nature of gene-editing approaches to agricultural and public health problems. 
 
 
3) What should be USDA’s role in applying gene editing in innovation (developing tools, 
techniques and methodologies), in meeting needs (applying to specific agricultural 
problems), both or neither? 
Gene editing, as a tool among many tools, can be useful to researchers and producers. It can help us 
understand genomes, solve problems in agricultural production systems, and achieve crop production 
goals. 
 
Most universities and agricultural industries are currently investing in gene editing research and in 
tool development and application. USDA’s role is to fund intramural and extramural research that 
advances our understanding of genome function, the development of the technology, and the 
application of the technology to crop production systems and to inform the public and agricultural 
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producers about the extent of gene editing activity and its effect on markets and consumer behaviors.  
 
Gene editing research and development is such a powerful tool, we expect to see it broadly used 
across major and minor crops. Of course, economically, there may be a move to market where 
specific germplasm varieties that will carry a positive  return on research and development 
investments. 
 
The choice to utilize gene editing as a fundamental tool has in many ways already been made, but 
the technology itself remains, as do all new technologies, somewhat controversial. USDA needs to 
make the technology accessible to all potential users and information about the pros and cons of the 
technology available and apparent to the general public.  Ultimately, USDA needs to be proactive 




4) Does USDA need to make statements on how it plans to use, or is using, gene editing in 
agricultural research? Why or why not? 
As technology affecting agriculture continues to make important progress, it is critical to ensure that 
stakeholders, including consumers, understand the benefits and trust the safety of ingredients that 
arise from the technology. Early education may help stakeholders understand the objectives of the 
technology and to build an appreciation and confidence when the ingredients make it to the market 
place. 
 
Science related to food can have a negative and inaccurate perception with consumers. When looked 
at from the point of view of families and children, food is very personal and emotional. Consumers 
desire to know more about the source of their food is increasing, and this is likely to continue with 
younger generations. Having a proactive and transparent approach from the start while 
communicating in a language consumers understand may help form long term trust and support in the 
technology. 
 
There are many positive examples to help educate stakeholders about agriculture research and the 
benefits to solving problems regarding climate change, quality, safety and disease, to name a few. The 
Hawaiian papaya GMO success is one such example. 
 
As we continue to have advance agriculture research, keeping in mind those who will ultimately 
consume the products is an important part of the process. 
 
 
5) What are the respective roles of the public sector and private sector (as it relates to 
research) in gene editing, and where do they overlap? 
 
The council established in deliberations a clear need for BOTH private sector and public-sector 
access to and development of these tools. The private sector should continue to push the rapid 
development of new products that are tailored to the market needs and address general societal 
demands as well as buyer/producer needs. The public sector carries a critical educational/training 
role across multiple technologies ensuring the workforce of the future is entered into by well-trained 
scientists who are skilled in the latest technology. Additionally, the public sector has a particularly 
important role in ensuring access to public products and materials, training and support of pre- 
competitive research (basic). In the world of major crops, there remains a need for public products 
that might not normally be produced under typical commercial circumstances yet still fill a valid 
market need. Illustration of these kinds of needs might include unique variants, organics, and other 
specialty market products. 
 
 
6) Are there any USDA priorities that can only be accomplished through gene editing 
that cannot be accomplished through conventional techniques? 
 
The council concluded that gene editing is not in itself a silver bullet because it is most readily 
applied presently to simple single-gene traits and may be limited in its application to more complex 
multi-gene or gene networks. In fact, a common use of the tool will simply be to discover the 
function of various single genes including confirmation of no impact. Following this ‘genetic 
mapping’ of function to gene, further studies will be needed to understand the variability and 
metabolic flux. Its application to important agricultural challenges will need to be strategic and 
based on this genetic mapping and metabolic assessment. Given the specificity of the CRISPR/Cas 
gene editing it will initially be most effective in targeting genes that control major pathways or are 
rate-limiting in key points in pathways critical to desired traits. 
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In contrast, complex gene networks often affect yield, major problems of interest, and interactions with 
multiple environmental factors. Thus, application of gene editing to such multifactorial pathways will 
require a deeper and more nuanced understanding of such complex networks, metabolomics and fluxes 
to identify genes to affect outcomes of interest to solve major agricultural problems. Further, multiple 
gene edits may be required in several key rate-limiting genes once these complex pathways are 
mapped and understood. Thus, on-going discovery foundational research is simultaneously needed 
even while initial application of gene editing to singe target genes for more simple traits is studied. 
Therefore, both short-term application and long-term exploratory research are needed to realize fully 
the ultimate potential of gene editing. Even so, a realistic view must understand that confirming the 
effect of a gene or elucidating a gene network in a research setting, may or may not have a clear 
practical outcome in the short-term. Gene editing becomes a pathway as well as a tool to find the end 
product or solution desired. 
 
The time required to elucidate complex genetic networks may exceed in some urgent cases the time 
available to solve the problems. For example, solving the citrus greening disease is good example of an 
urgent problem requiring a solution more rapid than gene editing might provide. Thus, the degree of 
foundational discovery needed and generation time are critical to consider in assessing the utility of 
gene editing approaches to the problem. This again emphasizes the nature of gene editing as one of 




7) What Priority should USDA give to gene editing in relationship to USDA’s existing prioritie, 
and why? 
 
After discussing this issue, the council concluded that gene editing will be an important tool to 
achieve many of its priorities such as increasing food production, and improving human nutrition and 
safety of food products. Like any other research tool, it should be developed and advanced for 
increased efficiency, accuracy, and understanding of its usefulness and applicability. Acquiring 
expertise on this tool will allow research in potential cures of genetic conditions, removal of bacterial 
factors, more targeted development of new drugs in shorter time, decreasing resistance to 
medications, and crop seed enhancement among others.
 
The limits of its usefulness is still unknown. 
The usefulness and limitations of gene editing in agriculture need further definition, therefore, it is 
critical to continue research in this field and to achieve increased expertise with this tool. For 
example, the Agriculture Risk Protection Act of 2000 gives the USDA the regulatory power over any 
genetically modified organism that utilizes the genome of a predefined 'plant pest' or any plant not 
previously categorized. The white button mushroom in 2015 was the first organism genetically 
modified with the CRISPR/cas9 protein system that overpassed US regulations, because its 
development by Yang et al. did not use any potential “plant pest” to insert genes. The USDA 
sponsored a committee in 2016 to consider future regulatory policy for these new genetic 
modification techniques, since these new techniques do not use “plant pests” like the GMOs, and, 
therefore, are not considered under the current “Coordinated Framework for Regulation of 
Biotechnology.” With the emergence of many scientists and engineers using the new technology, 
understanding its reach, potential and safety for food production and plant enhancement is imperative. 
Gene editing is causing a scientific revolution on how we are able to conduct research, therefore, 
USDA needs to be up front in its utilization and safety. The technology may be the base for a new 
green revolution with long-term and permanent consequences, and USDA needs to be prepared to use it 
effectively and foreseen and manage its long-term consequences. 
 
8) What should or can REE do, if anything, to enable a more democratized availability of gene 
editing technologies? (So that it is not only big companies that can use this technology.) 
 
The Council concluded that gene editing technology is most commonly utilized by research teams at 
universities throughout the country and private companies. As the techniques are incorporated into 
training programs for breeders, the technology will become even more widely available and more 
widely utilized. 
USDA REE agencies can fuel the growth and distribution of knowledge about the applicability of the 
technology, and facilitate broader accessibility to the technology with the following actions: 
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• Adopt and communicate an agency policy/mission statement that expresses their 
intention to support research, extension and education about this technology that 
promotes safety, proper application and increased agricultural productivity. 
• Provide intramural and extramural funding for research projects that expand the 
understanding and applicability of the technology.  
• Communicate across potential adopters and the general public about the nature and utility 
of the technology as well as the science behind the technology, and the opportunities and 
challenges associated with use of the technology. (See final recommendations of this 
report for implementation.) 
• Communicate with potential adopters and the general public about the relative safety of 
the technology.  
• Clarify and communicate to the research communities, potential adopters and the general 
public the product review processes that USDA and the private sector will employ to 
ensure proper use of the technology. 
 
 
9) Does USDA’s role change if gene editing can be detected in some or all products and, if so, 
how? Does USDA’s role change if gene editing cannot be detected in products and, if so, 
how? 
 
Gene editing technique is viewed as a transformational tool in agricultural research. For example, 
the CRISPR technique is so precise that it is considered the least biologically disruptive technique 
available to date. The USDA rightly considers gene edited crops as fundamentally different from 
GMOs and therefore does not warrant the same regulatory oversight. The Science Advisory Council 
of the NAREEE Board recommends that the USDA stay focused on use of gene editing for finding 
solutions to problems and outcomes rather than regulatory processes. 
The Council also concluded that an aggressive education and outreach program about the techniques 
used to select and bring a new gene edited product to market is critical. Poor communication and 
public outreach can potentially jeopardize the wide application of this revolutionary tool to address 
the daunting challenge of meeting the food demands of a rapidly growing world population. The 
public should not confuse gene edited foods with transgenic foods, although it is very likely to happen 
in the absence of outreach and education programs. Some practitioners of gene editing technique are 
apprehensive that the faction of the public that opposed GMOs at the beginning is likely to group 
these two together and oppose gene edited products as well. Such resistance can greatly impede our 
nation’s ability to be at the forefront of agricultural research and development and likely lose our 
competitive edge. 
The international response in terms of adopting and regulating gene editing in agriculture and food 
production varies from country to country. Chinese researchers, for example, quickly started adopting 
CRISPR in agriculture research as soon as the technique’s benefits became apparent. Sweden and 
Argentina have concluded that some mutations induced by CRISPR and some gene edited crops fall 
outside the definition and regulation of GMOs. Finland and Netherlands appear to be taking a similar 
approach at least for now, while non-governmental groups in France have shown resistance to this 
technology. Thus, several European countries, including Germany, are still debating whether or not to 
regulate gene editing technology in the absence of a clear direction by the European Union. Because 
CRISPR is accessible and inexpensive, it opens up the possibility of this powerful genetic 
modification tool falling into the wrong hands. There is a strong need for regulatory agencies to find 
foolproof ways to prevent misuse of this technology. This is particularly important for the US to be 
competitive globally, as misuse of CRISPR and mislabeling can possibly lead to exclusion of US 
products by foreign markets. 
 
10) What is USDA’s role, if any, in researching and/or communicating the social implications of gene 
editing?  (Note: USDA-NIFA programming in this area at the end of the provided current research 
information) 
When exploring the social implications, there are many issues involved, but perhaps one key tradeoff 
is to show that the benefits to society outweigh the risks. This requires transdisciplinary research to 
assess how consumers perceive risks and benefits (sociology and behavioral economics), potential 
productivity gains and ecological risks (biological sciences), as well as economic winners and losers, 
but such research requires a shared agenda among research teams. It may be that the traditional choice 
to commercialize and release safe products, might be adapted to include more social welfare 
considerations which include public release of alternative products. The mixed public attitude 
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regarding GMOs suggests that people are likely to accept gene-edited products but only if there is a 
dependable authority to substantiate the safety and educate the public. If so, further development, 
adoption and food business promotion may face a bottleneck that is somewhat constrained by uneven 
consumer acceptance of transgene-free food crops developed by genome editing. 
Developers of the technology should be encouraged to produce products with traits that would 
foremost satisfy consumer or social health needs and to create clear beneficial outcomes for the 
greatest share of the market/citizenry as possible. Moreover, better risk–benefit communication 
should be formulated as the government considers their regulatory status and establishes appropriate 
regulations. If careful risk–benefit communication is used at each stage of the development of 
transgene-free products, it will increase the chances they will be fully integrated into the marketplace 
and society. 
 
11) What actions, if any, need to be taken by the Chief Scientist to address issues raised in this 
report and are yet to be addressed? 
The Science Advisory Council recommends that the Chief Scientist should take the 
following actions: 
a. The Office of the Chief Scientist should review all USDA agencies and their current 
efforts to communicate about Gene Editing technology and encourage each 
appropriate agency to establish education and outreach efforts and programs to help 
explain the use of it as a tool. 
b. The Office of the Chief Scientist should encourage the use of multiple 
appropriate technologies to develop the best, effective and safe products to 
market 
c. The Office of the Chief Scientist should develop a comprehensive outreach strategy 
on gene editing, taking into consideration the public’s ethical, moral, cultural, 
philosophical, theological and ecological positions and beliefs. 
d. In addition, the guidelines established by agencies regulating gene editing in agriculture 
and food production should be shared by the Office of the Chief Scientist beyond the 
confines of the scientific society through outreach programs to enable the public to 
have difficult questions addressed and to ensure the public’s trust in regulatory 
measures. 
e. There is a general public perception that the scientific community is not accustomed to 
effectively communicating the details of research, its benefits, and more importantly, 
its potential unintended consequences to the public. The Office of the Chief Scientist 
and the Chief Scientist should urge land-grant institutions and everyone involved in 
agriculture and food production who receive USDA funding to aggressively 
campaign in favor of gene editing as an effective tool and recognizing its benefits. 
Strategic communication and sufficient follow-up are necessary while interacting 
with reporters to prevent distortion of science due to oversimplification of stories. 
Some experts have recommended active participation of all stakeholders in online 
discussions about the benefits of gene editing. Performance evaluations and reward 
systems for scientists should reflect the value and emphasis placed on public outreach 
as well. 
f. It is essential that the Office of the Chief Scientist be open in communications about 
benefits and risks of gene edition technology, including any chances of off-target 
mutations. This should be done in a manner that respects and guarantees the 
public’s right-to-know. 
g. The Office of the Chief Scientist and the Chief Scientist must also foster 
communication between public and biotech companies regarding the gene edited 
products released into the market. 
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